Prab at 23:51, 30 December 2024

2024-12-30T23:51:57Z

← Older revision		Revision as of 23:51, 30 December 2024
Line 1:		Line 1:
	~~{{Infobox protein~~
	~~\| name = KIT~~
	~~\| image = KIT_protein_structure.png~~
	~~\| caption = Structure of the KIT protein~~
	~~\| symbol = KIT~~
	~~\| HGNCid = 6342~~
	~~\| OMIM = 164920~~
	~~\| EntrezGene = 3815~~
	~~\| RefSeq = NM_000222~~
	~~\| UniProt = P10721~~
	}}

	'''KIT''', also known as '''CD117''', is a type of [[receptor tyrosine kinase]] that is encoded by the ''KIT'' gene in humans. This protein plays a crucial role in cell signaling, which is essential for various cellular processes including cell growth, differentiation, and survival. KIT is particularly important in the development and function of certain cell types, such as [[hematopoietic stem cells]], [[melanocytes]], and [[germ cells]].		'''KIT''', also known as '''CD117''', is a type of [[receptor tyrosine kinase]] that is encoded by the ''KIT'' gene in humans. This protein plays a crucial role in cell signaling, which is essential for various cellular processes including cell growth, differentiation, and survival. KIT is particularly important in the development and function of certain cell types, such as [[hematopoietic stem cells]], [[melanocytes]], and [[germ cells]].

Line 39:		Line 27:
	{{Receptor tyrosine kinases}}		{{Receptor tyrosine kinases}}
	{{Signal transduction}}		{{Signal transduction}}
			{{nt}}
	[[Category:Receptor tyrosine kinases]]		[[Category:Receptor tyrosine kinases]]
	[[Category:Oncology]]		[[Category:Oncology]]
	[[Category:Cell signaling]]		[[Category:Cell signaling]]

Prab: CSV import

2024-12-02T01:53:30Z

CSV import

New page

{{Infobox protein
| name = KIT
| image = KIT_protein_structure.png
| caption = Structure of the KIT protein
| symbol = KIT
| HGNCid = 6342
| OMIM = 164920
| EntrezGene = 3815
| RefSeq = NM_000222
| UniProt = P10721
}}

'''KIT''', also known as '''CD117''', is a type of [[receptor tyrosine kinase]] that is encoded by the ''KIT'' gene in humans. This protein plays a crucial role in cell signaling, which is essential for various cellular processes including cell growth, differentiation, and survival. KIT is particularly important in the development and function of certain cell types, such as [[hematopoietic stem cells]], [[melanocytes]], and [[germ cells]].

==Structure==
KIT is a transmembrane protein that consists of an extracellular domain, a transmembrane domain, and an intracellular tyrosine kinase domain. The extracellular domain is responsible for binding to its ligand, [[stem cell factor]] (SCF), which triggers dimerization and activation of the receptor.

==Function==
The primary function of KIT is to act as a receptor for stem cell factor (SCF), also known as steel factor or mast cell growth factor. Upon binding to SCF, KIT undergoes dimerization and autophosphorylation, activating its kinase activity. This activation initiates a cascade of downstream signaling pathways, including the [[PI3K/AKT pathway]], [[RAS/RAF/MEK/ERK pathway]], and [[JAK/STAT pathway]], which are involved in cell proliferation, survival, and differentiation.

==Clinical Significance==
Mutations in the ''KIT'' gene can lead to various diseases and conditions. Gain-of-function mutations are associated with several types of cancers, including [[gastrointestinal stromal tumors]] (GISTs), [[mastocytosis]], and certain types of [[leukemia]]. These mutations result in constitutive activation of the KIT receptor, leading to uncontrolled cell proliferation.

Loss-of-function mutations in KIT can result in [[piebaldism]], a condition characterized by patches of unpigmented skin and hair due to the absence of melanocytes.

==Therapeutic Target==
KIT is a target for several therapeutic agents, particularly in the treatment of cancers such as GISTs. [[Imatinib]], a tyrosine kinase inhibitor, is commonly used to treat GISTs by inhibiting the activity of mutant KIT proteins. Other inhibitors, such as [[sunitinib]] and [[regorafenib]], are also used in cases where imatinib resistance develops.

==Research==
Ongoing research is focused on understanding the detailed mechanisms of KIT signaling and its role in various diseases. There is also significant interest in developing new therapeutic agents that can more effectively target KIT and overcome resistance to current treatments.

==Also see==
* [[Receptor tyrosine kinase]]
* [[Stem cell factor]]
* [[Gastrointestinal stromal tumor]]
* [[Imatinib]]
* [[Piebaldism]]

{{Receptor tyrosine kinases}}
{{Signal transduction}}

[[Category:Receptor tyrosine kinases]]
[[Category:Oncology]]
[[Category:Cell signaling]]

KIT - Revision history

Prab at 23:51, 30 December 2024

Prab: CSV import